KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 116 filers reported holding KURA ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $846,443 | -76.8% | 80,004 | -28.5% | 0.00% | -90.0% |
Q4 2020 | $3,656,000 | +1524.9% | 111,936 | +707.9% | 0.02% | +900.0% |
Q2 2020 | $225,000 | -61.1% | 13,855 | -63.7% | 0.00% | -60.0% |
Q3 2019 | $579,000 | -91.5% | 38,184 | -89.0% | 0.01% | -91.1% |
Q2 2019 | $6,846,000 | +820.2% | 347,698 | +674.7% | 0.06% | +1300.0% |
Q1 2019 | $744,000 | +261.2% | 44,880 | +308.0% | 0.00% | -55.6% |
Q1 2018 | $206,000 | – | 11,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |